ConductScience.org, home

Paper41575672

Anti-obesity Pharmacotherapy for Transplant Recipients.

Haugen CE and 1 other. Curr Atheroscler Rep, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Anti-obesity Pharmacotherapy for Transplant Recipients. Papers, record 41575672. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41575672

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-obesity Pharmacotherapy for Transplant Recipients.
PubMed
Journal
Curr Atheroscler Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Haugen CEChristine Ehttps://orcid.org/0000-0001-5884-2604
2Orandi BJBabak Jhttps://orcid.org/0000-0001-6026-7135

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ObesityMajor topic
Kidney TransplantationMajor topic
Anti-Obesity AgentsMajor topic
Liver TransplantationMajor topic
Transplant RecipientsMajor topic
Humans

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139283612GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.JAMA Intern Med2024https://conductscience.org/library/papers/39283612PubMed
238993868Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis.Front Transplant2023https://conductscience.org/library/papers/38993868PubMed
339919868Nutrient-Stimulating Hormone-Based Therapies for Obesity.Endocrinol Metab Clin North Am2025https://conductscience.org/library/papers/39919868PubMed
49683204Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.Lancet1998https://conductscience.org/library/papers/9683204PubMed
531835505Weight Gain and De Novo Metabolic Disorders after Liver Transplantation.Nutrients2019https://conductscience.org/library/papers/31835505PubMed
639025300The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study.Endocr Pract2024https://conductscience.org/library/papers/39025300PubMed
735042452Recipient obesity as a risk factor in kidney transplantation.BMC Nephrol2022https://conductscience.org/library/papers/35042452PubMed
830325004National Trends in Liver Transplantation in Older Adults.J Am Geriatr Soc2018https://conductscience.org/library/papers/30325004PubMed
929026064The Effect of Recipient Body Mass Index and Its Extremes on Survival and Graft Vascular and Biliary Complications After Liver Transplantation: A Single Center Retrospective Study.Ann Transplant2017https://conductscience.org/library/papers/29026064PubMed
1017081230Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial.Transpl Int2006https://conductscience.org/library/papers/17081230PubMed
1118497684Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation.Transplantation2008https://conductscience.org/library/papers/18497684PubMed
1232301874KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.Transplantation2020https://conductscience.org/library/papers/32301874PubMed
1312087008Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.Diabetes Care2002https://conductscience.org/library/papers/12087008PubMed
1420673995Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Lancet2010https://conductscience.org/library/papers/20673995PubMed
1523744721Comparable graft and patient survival in lean and obese liver transplant recipients.Liver Transpl2013https://conductscience.org/library/papers/23744721PubMed
169702435Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.Diabetes Care1998https://conductscience.org/library/papers/9702435PubMed
1737119856Recipient race modifies the association between obesity and long-term graft outcomes after kidney transplantation.Am J Transplant2023https://conductscience.org/library/papers/37119856PubMed
1810693734Orlistat in the long-term treatment of obesity in primary care settings.Arch Fam Med2000https://conductscience.org/library/papers/10693734PubMed
1916802443Anti-obesity therapies.Nat Rev Drug Discov2006https://conductscience.org/library/papers/16802443PubMed
2034714569A meta-analysis of the cumulative incidence, risk factors, and clinical outcomes associated with chronic kidney disease after liver transplantation.Transpl Int2021https://conductscience.org/library/papers/34714569PubMed

See all 103 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42074719Insulin Resistance and Atherogenic Dyslipidemia Drive Cardiac Remodeling and Cardiovascular Events After Kidney Transplantation.J Clin Med2026https://conductscience.org/library/papers/42074719

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GIP2695PubTator's text mininghttps://conductscience.org/library/genes/2695NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41575672

GET https://conductscience.org/api/papers/v1/41575672/references?page=2